Transcriptomics

Dataset Information

0

Impaired tumor death receptor signaling drives resistance to CAR T cell therapy

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE130663 | GEO | 2020/02/17

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics Impaired tumor death receptor signaling drives resistance to CAR T cell therapy
| PRJNA541515 | ENA
Unknown Tumor-intrinsic interferon signaling drives pancreatic cancer resistance to tumor mucin1-targeted CAR T cell therapy
| S-EPMC12370727 | biostudies-literature
Unknown Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.
| S-EPMC7416790 | biostudies-literature
Transcriptomics VGLL1 drives therapy resistance in estrogen receptor positive breast cancer
2023-12-05 | GSE216530 | GEO
Unknown Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.
| S-EPMC10371011 | biostudies-literature
Unknown Overcoming tumor resistance mechanisms in CAR-NK cell therapy.
| S-EPMC9381932 | biostudies-literature
Unknown Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL.
| S-EPMC12082145 | biostudies-literature
Unknown GPR65 Inactivation in Tumor Cells Drives Antigen-Independent CAR T-cell Resistance via Macrophage Remodeling.
| S-EPMC12046320 | biostudies-literature
Unknown The Janus Face of Death Receptor Signaling during Tumor Immunoediting.
| S-EPMC5086583 | biostudies-literature
Unknown A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance.
| S-EPMC10643940 | biostudies-literature